1. Executive Summary
1.1. Global Neurosurgery Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter’s Five Forces Analysis
2.5. COVID-19 Impact Analysis
2.5.1. Supply
2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
2.7.1. World Economic Projections
2.8. PESTLE Analysis
3. Global Neurosurgery Market Outlook, 2018 - 2031
3.1. Global Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
3.1.1. Key Highlights
3.1.1.1. Neuro Interventional Devices
3.1.1.1.1. Neurovascular Embolization Devices
3.1.1.1.1.1. Embolization Coils
3.1.1.1.1.2. Liquid Embolic Systems
3.1.1.1.1.3. Flow Diversion Stents
3.1.1.1.1.4. Aneurysm Clips
3.1.1.1.2. Neurovascular Coiling Assist Devices
3.1.1.1.2.1. Coiling Assist Stents
3.1.1.1.2.2. Coiling Assist Balloons
3.1.1.1.3. Neurovascular Thrombectomy Devices
3.1.1.1.3.1. Stent Retrievers
3.1.1.1.3.2. Aspiration Retrievers
3.1.1.1.4. Microguidewires
3.1.1.1.5. Microcatheters
3.1.1.1.6. Support Catheters
3.1.1.1.7. Intracranial Stents
3.1.1.2. Neuroendoscopes
3.1.1.2.1. Flexible Neuroendoscopes
3.1.1.2.2. Rigid Neuroendoscopes
3.1.1.3. Neurosurgical Drills
3.1.1.3.1. Pneumatic Neurosurgical Drills
3.1.1.3.2. Electrical Neurosurgical Drills
3.1.1.4. Radiosurgery Systems
3.1.1.4.1. Linear Accelerator Radiosurgery Systems
3.1.1.4.2. GammaKnife Radiosurgery Systems
3.1.1.5. Dura Substitutes
3.1.1.5.1. Biological Dura Substitutes
3.1.1.5.2. Synthetic Dura Substitutes
3.1.1.6. Neurosurgical Ablation Devices
3.1.1.6.1. MRI Guided Focused Ultrasound Systems
3.1.1.6.2. MRI Guided Laser Therapy Systems
3.1.1.6.3. MRI Guided RF Ablation Systems
3.1.1.7. Neurosurgery Instruments
3.1.1.7.1. Tissue Retractors
3.1.1.7.2. Forceps
3.1.1.7.3. Head Frames
3.1.1.7.4. Cervical Plating systems
3.1.1.7.5. Perforators
3.2. Global Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
3.2.1. Key Highlights
3.2.1.1. Hospitals
3.2.1.2. Ambulatory Surgical Centres
3.2.1.3. Specialized Neurological Institutes
3.3. Global Neurosurgery Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
3.3.1. Key Highlights
3.3.1.1. North America
3.3.1.2. Europe
3.3.1.3. Asia Pacific
3.3.1.4. Latin America
3.3.1.5. Middle East & Africa
4. North America Neurosurgery Market Outlook, 2018 - 2031
4.1. North America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
4.1.1. Key Highlights
4.1.1.1. Neuro Interventional Devices
4.1.1.1.1. Neurovascular Embolization Devices
4.1.1.1.1.1. Embolization Coils
4.1.1.1.1.2. Liquid Embolic Systems
4.1.1.1.1.3. Flow Diversion Stents
4.1.1.1.1.4. Aneurysm Clips
4.1.1.1.2. Neurovascular Coiling Assist Devices
4.1.1.1.2.1. Coiling Assist Stents
4.1.1.1.2.2. Coiling Assist Balloons
4.1.1.1.3. Neurovascular Thrombectomy Devices
4.1.1.1.3.1. Stent Retrievers
4.1.1.1.3.2. Aspiration Retrievers
4.1.1.1.4. Microguidewires
4.1.1.1.5. Microcatheters
4.1.1.1.6. Support Catheters
4.1.1.1.7. Intracranial Stents
4.1.1.2. Neuroendoscopes
4.1.1.2.1. Flexible Neuroendoscopes
4.1.1.2.2. Rigid Neuroendoscopes
4.1.1.3. Neurosurgical Drills
4.1.1.3.1. Pneumatic Neurosurgical Drills
4.1.1.3.2. Electrical Neurosurgical Drills
4.1.1.4. Radiosurgery Systems
4.1.1.4.1. Linear Accelerator Radiosurgery Systems
4.1.1.4.2. GammaKnife Radiosurgery Systems
4.1.1.5. Dura Substitutes
4.1.1.5.1. Biological Dura Substitutes
4.1.1.5.2. Synthetic Dura Substitutes
4.1.1.6. Neurosurgical Ablation Devices
4.1.1.6.1. MRI Guided Focused Ultrasound Systems
4.1.1.6.2. MRI Guided Laser Therapy Systems
4.1.1.6.3. MRI Guided RF Ablation Systems
4.1.1.7. Neurosurgery Instruments
4.1.1.7.1. Tissue Retractors
4.1.1.7.2. Forceps
4.1.1.7.3. Head Frames
4.1.1.7.4. Cervical Plating systems
4.1.1.7.5. Perforators
4.2. North America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
4.2.1. Key Highlights
4.2.1.1. Hospitals
4.2.1.2. Ambulatory Surgical Centres
4.2.1.3. Specialized Neurological Institutes
4.3. North America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
4.3.1. Key Highlights
4.3.1.1. U.S. Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
4.3.1.2. U.S. Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
4.3.1.3. Canada Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
4.3.1.4. Canada Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
4.3.2. BPS Analysis/Market Attractiveness Analysis
5. Europe Neurosurgery Market Outlook, 2018 - 2031
5.1. Europe Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
5.1.1. Key Highlights
5.1.1.1. Neuro Interventional Devices
5.1.1.1.1. Neurovascular Embolization Devices
5.1.1.1.1.1. Embolization Coils
5.1.1.1.1.2. Liquid Embolic Systems
5.1.1.1.1.3. Flow Diversion Stents
5.1.1.1.1.4. Aneurysm Clips
5.1.1.1.2. Neurovascular Coiling Assist Devices
5.1.1.1.2.1. Coiling Assist Stents
5.1.1.1.2.2. Coiling Assist Balloons
5.1.1.1.3. Neurovascular Thrombectomy Devices
5.1.1.1.3.1. Stent Retrievers
5.1.1.1.3.2. Aspiration Retrievers
5.1.1.1.4. Microguidewires
5.1.1.1.5. Microcatheters
5.1.1.1.6. Support Catheters
5.1.1.1.7. Intracranial Stents
5.1.1.2. Neuroendoscopes
5.1.1.2.1. Flexible Neuroendoscopes
5.1.1.2.2. Rigid Neuroendoscopes
5.1.1.3. Neurosurgical Drills
5.1.1.3.1. Pneumatic Neurosurgical Drills
5.1.1.3.2. Electrical Neurosurgical Drills
5.1.1.4. Radiosurgery Systems
5.1.1.4.1. Linear Accelerator Radiosurgery Systems
5.1.1.4.2. GammaKnife Radiosurgery Systems
5.1.1.5. Dura Substitutes
5.1.1.5.1. Biological Dura Substitutes
5.1.1.5.2. Synthetic Dura Substitutes
5.1.1.6. Neurosurgical Ablation Devices
5.1.1.6.1. MRI Guided Focused Ultrasound Systems
5.1.1.6.2. MRI Guided Laser Therapy Systems
5.1.1.6.3. MRI Guided RF Ablation Systems
5.1.1.7. Neurosurgery Instruments
5.1.1.7.1. Tissue Retractors
5.1.1.7.2. Forceps
5.1.1.7.3. Head Frames
5.1.1.7.4. Cervical Plating systems
5.1.1.7.5. Perforators
5.2. Europe Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
5.2.1. Key Highlights
5.2.1.1. Hospitals
5.2.1.2. Ambulatory Surgical Centres
5.2.1.3. Specialized Neurological Institutes
5.2.2. BPS Analysis/Market Attractiveness Analysis
5.3. Europe Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
5.3.1. Key Highlights
5.3.1.1. Germany Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.2. Germany Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.3. U.K. Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.4. U.K. Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.5. France Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.6. France Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.7. Italy Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.8. Italy Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.9. Turkey Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.10. Turkey Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.11. Russia Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.12. Russia Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.1.13. Rest of Europe Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
5.3.1.14. Rest of Europe Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
5.3.2. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Neurosurgery Market Outlook, 2018 - 2031
6.1. Asia Pacific Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
6.1.1. Key Highlights
6.1.1.1. Neuro Interventional Devices
6.1.1.1.1. Neurovascular Embolization Devices
6.1.1.1.1.1. Embolization Coils
6.1.1.1.1.2. Liquid Embolic Systems
6.1.1.1.1.3. Flow Diversion Stents
6.1.1.1.1.4. Aneurysm Clips
6.1.1.1.2. Neurovascular Coiling Assist Devices
6.1.1.1.2.1. Coiling Assist Stents
6.1.1.1.2.2. Coiling Assist Balloons
6.1.1.1.3. Neurovascular Thrombectomy Devices
6.1.1.1.3.1. Stent Retrievers
6.1.1.1.3.2. Aspiration Retrievers
6.1.1.1.4. Microguidewires
6.1.1.1.5. Microcatheters
6.1.1.1.6. Support Catheters
6.1.1.1.7. Intracranial Stents
6.1.1.2. Neuroendoscopes
6.1.1.2.1. Flexible Neuroendoscopes
6.1.1.2.2. Rigid Neuroendoscopes
6.1.1.3. Neurosurgical Drills
6.1.1.3.1. Pneumatic Neurosurgical Drills
6.1.1.3.2. Electrical Neurosurgical Drills
6.1.1.4. Radiosurgery Systems
6.1.1.4.1. Linear Accelerator Radiosurgery Systems
6.1.1.4.2. GammaKnife Radiosurgery Systems
6.1.1.5. Dura Substitutes
6.1.1.5.1. Biological Dura Substitutes
6.1.1.5.2. Synthetic Dura Substitutes
6.1.1.6. Neurosurgical Ablation Devices
6.1.1.6.1. MRI Guided Focused Ultrasound Systems
6.1.1.6.2. MRI Guided Laser Therapy Systems
6.1.1.6.3. MRI Guided RF Ablation Systems
6.1.1.7. Neurosurgery Instruments
6.1.1.7.1. Tissue Retractors
6.1.1.7.2. Forceps
6.1.1.7.3. Head Frames
6.1.1.7.4. Cervical Plating systems
6.1.1.7.5. Perforators
6.2. Asia Pacific Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
6.2.1. Key Highlights
6.2.1.1. Hospitals
6.2.1.2. Ambulatory Surgical Centres
6.2.1.3. Specialized Neurological Institutes
6.2.2. Others BPS Analysis/Market Attractiveness Analysis
6.3. Asia Pacific Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
6.3.1. Key Highlights
6.3.1.1. China Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.2. China Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.3. Japan Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.4. Japan Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.5. South Korea Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.6. South Korea Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.7. India Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.8. India Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.9. Southeast Asia Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.10. Southeast Asia Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.1.11. Rest of Asia Pacific Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
6.3.1.12. Rest of Asia Pacific Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
6.3.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Neurosurgery Market Outlook, 2018 - 2031
7.1. Latin America Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
7.1.1. Key Highlights
7.1.1.1. Neuro Interventional Devices
7.1.1.1.1. Neurovascular Embolization Devices
7.1.1.1.1.1. Embolization Coils
7.1.1.1.1.2. Liquid Embolic Systems
7.1.1.1.1.3. Flow Diversion Stents
7.1.1.1.1.4. Aneurysm Clips
7.1.1.1.2. Neurovascular Coiling Assist Devices
7.1.1.1.2.1. Coiling Assist Stents
7.1.1.1.2.2. Coiling Assist Balloons
7.1.1.1.3. Neurovascular Thrombectomy Devices
7.1.1.1.3.1. Stent Retrievers
7.1.1.1.3.2. Aspiration Retrievers
7.1.1.1.4. Microguidewires
7.1.1.1.5. Microcatheters
7.1.1.1.6. Support Catheters
7.1.1.1.7. Intracranial Stents
7.1.1.2. Neuroendoscopes
7.1.1.2.1. Flexible Neuroendoscopes
7.1.1.2.2. Rigid Neuroendoscopes
7.1.1.3. Neurosurgical Drills
7.1.1.3.1. Pneumatic Neurosurgical Drills
7.1.1.3.2. Electrical Neurosurgical Drills
7.1.1.4. Radiosurgery Systems
7.1.1.4.1. Linear Accelerator Radiosurgery Systems
7.1.1.4.2. GammaKnife Radiosurgery Systems
7.1.1.5. Dura Substitutes
7.1.1.5.1. Biological Dura Substitutes
7.1.1.5.2. Synthetic Dura Substitutes
7.1.1.6. Neurosurgical Ablation Devices
7.1.1.6.1. MRI Guided Focused Ultrasound Systems
7.1.1.6.2. MRI Guided Laser Therapy Systems
7.1.1.6.3. MRI Guided RF Ablation Systems
7.1.1.7. Neurosurgery Instruments
7.1.1.7.1. Tissue Retractors
7.1.1.7.2. Forceps
7.1.1.7.3. Head Frames
7.1.1.7.4. Cervical Plating systems
7.1.1.7.5. Perforators
7.2. Latin America Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
7.2.1. Key Highlights
7.2.1.1. Hospitals
7.2.1.2. Ambulatory Surgical Centres
7.2.1.3. Specialized Neurological Institutes
7.2.2. BPS Analysis/Market Attractiveness Analysis
7.3. Latin America Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
7.3.1. Key Highlights
7.3.1.1. Brazil Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.2. Brazil Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.3. Mexico Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.4. Mexico Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.5. Argentina Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.6. Argentina Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
7.3.1.7. Rest of Latin America Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
7.3.1.8. Rest of Latin America Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
7.3.2. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Neurosurgery Market Outlook, 2018 - 2031
8.1. Middle East & Africa Neurosurgery Market Outlook, by Product, Value (US$ Bn), 2018 - 2031
8.1.1. Key Highlights
8.1.1.1. Neuro Interventional Devices
8.1.1.1.1. Neurovascular Embolization Devices
8.1.1.1.1.1. Embolization Coils
8.1.1.1.1.2. Liquid Embolic Systems
8.1.1.1.1.3. Flow Diversion Stents
8.1.1.1.1.4. Aneurysm Clips
8.1.1.1.2. Neurovascular Coiling Assist Devices
8.1.1.1.2.1. Coiling Assist Stents
8.1.1.1.2.2. Coiling Assist Balloons
8.1.1.1.3. Neurovascular Thrombectomy Devices
8.1.1.1.3.1. Stent Retrievers
8.1.1.1.3.2. Aspiration Retrievers
8.1.1.1.4. Microguidewires
8.1.1.1.5. Microcatheters
8.1.1.1.6. Support Catheters
8.1.1.1.7. Intracranial Stents
8.1.1.2. Neuroendoscopes
8.1.1.2.1. Flexible Neuroendoscopes
8.1.1.2.2. Rigid Neuroendoscopes
8.1.1.3. Neurosurgical Drills
8.1.1.3.1. Pneumatic Neurosurgical Drills
8.1.1.3.2. Electrical Neurosurgical Drills
8.1.1.4. Radiosurgery Systems
8.1.1.4.1. Linear Accelerator Radiosurgery Systems
8.1.1.4.2. GammaKnife Radiosurgery Systems
8.1.1.5. Dura Substitutes
8.1.1.5.1. Biological Dura Substitutes
8.1.1.5.2. Synthetic Dura Substitutes
8.1.1.6. Neurosurgical Ablation Devices
8.1.1.6.1. MRI Guided Focused Ultrasound Systems
8.1.1.6.2. MRI Guided Laser Therapy Systems
8.1.1.6.3. MRI Guided RF Ablation Systems
8.1.1.7. Neurosurgery Instruments
8.1.1.7.1. Tissue Retractors
8.1.1.7.2. Forceps
8.1.1.7.3. Head Frames
8.1.1.7.4. Cervical Plating systems
8.1.1.7.5. Perforators
8.2. Middle East & Africa Neurosurgery Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
8.2.1. Key Highlights
8.2.1.1. Hospitals
8.2.1.2. Ambulatory Surgical Centres
8.2.1.3. Specialized Neurological Institutes
8.2.2. BPS Analysis/Market Attractiveness Analysis
8.3. Middle East & Africa Neurosurgery Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
8.3.1. Key Highlights
8.3.1.1. GCC Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.2. GCC Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.3. South Africa Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.4. South Africa Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.5. Egypt Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.6. Egypt Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.7. Nigeria Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.8. Nigeria Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.1.9. Rest of Middle East & Africa Neurosurgery Market by Product, Value (US$ Bn), 2018 - 2031
8.3.1.10. Rest of Middle East & Africa Neurosurgery Market by End User, Value (US$ Bn), 2018 - 2031
8.3.2. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
9.1. Product vs by End User Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
9.4.1. B. Braun Melsungen AG
9.4.1.1. Company Overview
9.4.1.2. Product Portfolio
9.4.1.3. Financial Overview
9.4.1.4. Business Strategies and Development
9.4.2. Medtronic plc
9.4.2.1. Company Overview
9.4.2.2. Product Portfolio
9.4.2.3. Financial Overview
9.4.2.4. Business Strategies and Development
9.4.3. DePuy Synthes
9.4.3.1. Company Overview
9.4.3.2. Product Portfolio
9.4.3.3. Financial Overview
9.4.3.4. Business Strategies and Development
9.4.4. Boston Scientific
9.4.4.1. Company Overview
9.4.4.2. Product Portfolio
9.4.4.3. Financial Overview
9.4.4.4. Business Strategies and Development
9.4.5. Stryker Corp.
9.4.5.1. Company Overview
9.4.5.2. Product Portfolio
9.4.5.3. Financial Overview
9.4.5.4. Business Strategies and Development
9.4.6. Terumo Corporation
9.4.6.1. Company Overview
9.4.6.2. Product Portfolio
9.4.6.3. Financial Overview
9.4.6.4. Business Strategies and Development
9.4.7. KARL STORZ GmbH & Co KG
9.4.7.1. Company Overview
9.4.7.2. Product Portfolio
9.4.7.3. Financial Overview
9.4.7.4. Business Strategies and Development
9.4.8. Integra LifeSciences
9.4.8.1. Company Overview
9.4.8.2. Product Portfolio
9.4.8.3. Financial Overview
9.4.8.4. Business Strategies and Development
9.4.9. Penumbra Inc
9.4.9.1. Company Overview
9.4.9.2. Product Portfolio
9.4.9.3. Financial Overview
9.4.9.4. Business Strategies and Development
9.4.10. Adeor Medical AG
9.4.10.1. Company Overview
9.4.10.2. Product Portfolio
9.4.10.3. Financial Overview
9.4.10.4. Business Strategies and Development
9.4.11. Elekta
9.4.11.1. Company Overview
9.4.11.2. Product Portfolio
9.4.11.3. Financial Overview
9.4.11.4. Business Strategies and Development
10. Appendix
10.1.Research Methodology
10.2.Report Assumptions
10.3.Acronyms and Abbreviations